SCD1 Expression Is Dispensable for Hepatocarcinogenesis Induced by AKT and Ras Oncogenes in Mice

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Li, Lei ^a,b   Wang, Chunmei ^a   Calvisi, Diego F ^c   Evert, Matthias ^d   Pilo, Maria G ^c   Jiang, Lijie ^a   Yuneva, Mariia ^a   Chen, Xin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF SASSARI   (Italy)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; PROTEIN KINASE B; PROTEIN SCD2; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY LIVER; FEMALE; GENE; GENE OVEREXPRESSION; GENE SILENCING; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LIPID ANALYSIS; LIPID COMPOSITION; LIPOGENESIS; LIVER CARCINOGENESIS; MALE; MOUSE; MYRISTYLATION; NONHUMAN; ONCOGENE AKT; ONCOGENE RAS; SCD1 GENE; SCD2 GENE; SCD3 GENE; SCD4 GENE; WILD TYPE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; GENE EXPRESSION; GENES, RAS; LIPID METABOLISM; LIVER NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; MICE, NUDE; PROTO-ONCOGENE PROTEINS C-AKT; STEAROYL-COA DESATURASE;

EID: 84884402458     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075104     Document Type: Article

References (34)

1. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576. doi:10.1053/j.gastro.2007.04.061. PubMed: 17570226.
2. Bruix J, Boix L, Sala M, Llovet JM, (2004) Focus on hepatocellular carcinoma. Cancer Cell 5: 215-219. doi:10.1016/S1535-6108(04)00058-3. PubMed: 15050913.
3. Llovet JM, Bruix J, (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48 (Suppl 1):: S20-S37. doi:10.1016/S0168-8278(08)60049-5. PubMed: 18304676.
4. Spangenberg HC, Thimme R, Blum HE, (2009) Targeted therapy for hepatocellular carcinoma. Nat. Rev Gastroenterol Hepatol 6: 423-432. doi:10.1038/nrgastro.2009.86.
5. Furuta E, Okuda H, Kobayashi A, Watabe K, (2010) Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta 1805: 141-152. PubMed: 20122995.
6. Cairns RA, Harris IS, Mak TW, (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11: 85-95. doi:10.1038/nrc2981. PubMed: 21258394.
7. Mashima T, Seimiya H, Tsuruo T, (2009) De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer 100: 1369-1372. doi:10.1038/sj.bjc.6605007. PubMed: 19352381.
8. Menendez JA, Lupu R, (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777. doi:10.1038/nrc2222. PubMed: 17882277.
9. Ntambi JM, Miyazaki M, (2003) Recent insights into stearoyl-CoA desaturase-1. Curr Opin Lipidol 14: 255-261. doi:10.1097/00041433-200306000-00005. PubMed: 12840656.
10. Hodson L, Fielding BA, (2013) Stearoyl-CoA desaturase: rogue or innocent bystander? Prog Lipid Res 52: 15-42. doi:10.1016/j.plipres.2012.08.002. PubMed: 23000367.
11. Igal RA, (2010) Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 31: 1509-1515. doi:10.1093/carcin/bgq131. PubMed: 20595235.
12. Hess D, Chisholm JW, Igal RA, (2010) Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLOS ONE 5: e11394. doi:10.1371/journal.pone.0011394. PubMed: 20613975.
13. Minville-Walz M, Pierre AS, Pichon L, Bellenger S, Fèvre C, et al. (2010) Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLOS ONE 5: e14363. doi:10.1371/journal.pone.0014363. PubMed: 21179554.
14. Morgan-Lappe SE, Tucker LA, Huang X, Zhang Q, Sarthy AV, et al. (2007) Identification of Ras-related nuclear protein, targeting protein for Xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen. Cancer Res 67: 4390-4398. doi:10.1158/0008-5472.CAN-06-4132. PubMed: 17483353.
15. Hirsch HA, Iliopoulos D, Joshi A, Zhang Y, Jaeger SA, et al. (2010) A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 17: 348-361. doi:10.1016/j.ccr.2010.01.022. PubMed: 20385360.
16. Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39: 171-183. doi:10.1016/j.molcel.2010.06.022. PubMed: 20670887.
17. Moon YA, Liang G, Xie X, Frank-Kamenetsky M, Fitzgerald K, et al. (2012) The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab 15: 240-246. doi:10.1016/j.cmet.2011.12.017. PubMed: 22326225.
18. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, et al. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8: 224-236. doi:10.1016/j.cmet.2008.07.007. PubMed: 18762023.
19. Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, et al. (2011) Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140: 1071-1083. doi:10.1053/j.gastro.2010.12.006. PubMed: 21147110.
20. Ho C, Wang C, Mattu S, Destefanis G, Ladu S, et al. (2012) AKT (v-akt murine thymoma viral oncogene homologue 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. Hepatology 55: 833-845. doi:10.1002/hep.24736. PubMed: 21993994.
21. Fan L, Xu C, Wang C, Tao J, Ho C, et al. (2012) Bmi1 is required for hepatic progenitor cell expansion and liver tumor development. PLOS ONE 7: e46472. doi:10.1371/journal.pone.0046472. PubMed: 23029524.
22. Dobrzyn P, Dobrzyn A, Miyazaki M, Cohen P, Asilmaz E, et al. (2004) Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A 101: 6409-6414. doi:10.1073/pnas.0401627101. PubMed: 15096593.
23. Lee SA, Ho C, Roy R, Kosinski C, Patil MA, et al. (2008) Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer. Hepatology 47: 1200-1210. PubMed: 18214995.
24. Carlson CM, Frandsen JL, Kirchhof N, McIvor RS, Largaespada DA, (2005) Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse. Proc Natl Acad Sci U S A 102: 17059-17064. doi:10.1073/pnas.0502974102. PubMed: 16286660.
25. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509. PubMed: 13428781.
26. Morrison WR, Smith LM, (1964) Preparation of Fatty Acid Methyl Esters and Dimethylacetals from Lipids with Boron Fluoride--Methanol. J Lipid Res 5: 600-608. PubMed: 14221106.
27. Ntambi JM, Miyazaki M, Dobrzyn A, (2004) Regulation of stearoyl-CoA desaturase expression. Lipids 39: 1061-1065. doi:10.1007/s11745-004-1331-2. PubMed: 15726820.
28. Chu K, Miyazaki M, Man WC, Ntambi JM, (2006) Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol 26: 6786-6798. doi:10.1128/MCB.00077-06. PubMed: 16943421.
29. López M, Lelliott CJ, Tovar S, Kimber W, Gallego R, et al. (2006) Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 55: 1327-1336. doi:10.2337/db05-1356. PubMed: 16644689.
30. Mason P, Liang B, Li L, Fremgen T, Murphy E, et al. (2012) SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLOS ONE 7: e33823. doi:10.1371/journal.pone.0033823. PubMed: 22457791.
31. Bakan I, Laplante M, (2012) Connecting mTORC1 signaling to SREBP-1 activation. Curr Opin Lipidol 23: 226-234. doi:10.1097/MOL.0b013e328352dd03. PubMed: 22449814.
32. Luyimbazi D, Akcakanat A, McAuliffe PF, Zhang L, Singh G, et al. (2010) Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer. Mol Cancer Ther 9: 2770-2784. doi:10.1158/1535-7163.MCT-09-0980. PubMed: 20876744.
33. Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, et al. (2010) Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 9: 1740-1754. doi:10.1158/1535-7163.MCT-09-1064. PubMed: 20530718.
34. Wuestefeld T, Pesic M, Rudalska R, Dauch D, Longerich T, et al. (2013) A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration. Cell 153: 389-401. doi:10.1016/j.cell.2013.03.026. PubMed: 23582328.